The impact of SARS-COV-2 on biomanufacturing operations
The spread of COVID-19, which is caused by SARS-CoV-2, an enveloped, single-stranded RNA virus, was declared a global pandemic on March 11, 2020, and the virus has infected millions of individuals and led to hundreds of thousands of deaths. One of the main approaches used to mitigate the spread of t...
Main Authors: | Barone, Paul, Keumurian, Flora J., Wiebe, Michael E, Wolfrum, Jacqueline M, Leung, JC, Sinskey, Anthony J, Springs, SL |
---|---|
Other Authors: | Massachusetts Institute of Technology. Center for Biomedical Innovation |
Format: | Article |
Language: | English |
Published: |
2021
|
Online Access: | https://hdl.handle.net/1721.1/131200 |
Similar Items
-
Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2
by: Guttieres, Donovan, et al.
Published: (2021) -
Biomanufacturing /
by: Zhong, Jian-Jiang, et al.
Published: (2004) -
Revolutionizing standard operating procedures in biomanufacturing
by: Nag, Aditya
Published: (2013) -
Reducing complexity In biomanufacturing operations through single-use assemblies
by: Alfano, Edward J. (Edward James)
Published: (2012) -
Advancing lean implementation for next generation biomanufacturing operations
by: Jensen, Joshua David
Published: (2016)